Cytek wins on most Beckman patent claims; jury awards $56 million damages on remaining count
CTKB•Jury verdict in Beckman patent case
- Jury verdict in Delaware patent case brought by Beckman: noninfringement or invalidity on three of four asserted claims.
- One claim found infringed under doctrine of equivalents despite no literal infringement; past damages set at USD 56 million.
- Cytek plans post-verdict motions challenging the infringement finding and damages; appeal to the Federal Circuit remains possible.
- Verdict does not require changes to current products or operations; spectral flow cytometry products remain available worldwide.
Related News
James River 2Q26 net income rises 59% to $4.4 million; group combined ratio widens 1.6 percentage points to 100.2%
JRVR•
Northrop Grumman grants CEO Kathy Warden 35,910 performance-based market stock units tied to shares through 2031
NOC•
